Deals
Express Scripts Agrees to Buy Medco for $29.1 Billion
This article is for subscribers only.
Express Scripts Inc. agreed to buy Medco Health Solutions Inc. for $29.1 billion in the largest deal in at least a decade among U.S. companies that manage prescription-drug benefits.
The $71.36-a-share offer in cash and stock is 28 percent more than Medco’s $55.78 closing price yesterday. Investors in the Franklin Lakes, New Jersey-based company will get $28.80 in cash and 0.81 of an Express Scripts share for each Medco share they own at the closing, the companies said in a statement.